Sleep disturbances and nightmares in a patient treated with prazosin

Journal of Clinical Sleep Medicine

Volumn 12, Issue 4, 2016, Pages 631-632

  Kosari, Sam ^a   Naunton, Mark ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Adverse effects; Nightmares; Prazosin

Indexed keywords

DUTASTERIDE; PRAZOSIN; TAMSULOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HALLUCINATION; HUMAN; HYPERCHOLESTEROLEMIA; INSOMNIA; MALE; MENTAL DISEASE; NIGHTMARE; OSTEOARTHRITIS; PROSTATE HYPERTROPHY; RISK FACTOR; SLEEP DISORDER; CHEMICALLY INDUCED; DREAM; DRUG EFFECTS;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; DREAMS; HUMANS; MALE; PRAZOSIN; RISK FACTORS; SLEEP WAKE DISORDERS;

EID: 84969222310     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.5708     Document Type: Article

References (5)

1. Berardis DD, Marini S, Serroni N, Iasevoli N, et al. Targeting the noradrenergic system in posttraumatic stress disorder: a systematic review and metaanalysis of prazosin trials. Curr Drug Targets 2015;16:1094-106
2. Green B. Prazosin in the treatment of PTSD. J Psychiatr Pract 2014;20:253-9
3. Pfizer. MINIPRESS (prazosin HCl) 2015. Available from: https://www. pfizermedicalinformation.com/en-us/minipress
4. Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry 2013;170:1003-10
5. Reardon CL, Factor RM. Bizarre behavior in a patient treated with prazosin for PTSD. Am J Psychiatry 2008;165:774-5